JP2015522077A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015522077A5 JP2015522077A5 JP2015521792A JP2015521792A JP2015522077A5 JP 2015522077 A5 JP2015522077 A5 JP 2015522077A5 JP 2015521792 A JP2015521792 A JP 2015521792A JP 2015521792 A JP2015521792 A JP 2015521792A JP 2015522077 A5 JP2015522077 A5 JP 2015522077A5
- Authority
- JP
- Japan
- Prior art keywords
- amount
- fampridine
- laquinimod
- pharmaceutical composition
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261670758P | 2012-07-12 | 2012-07-12 | |
| US61/670,758 | 2012-07-12 | ||
| PCT/US2013/050001 WO2014011827A1 (en) | 2012-07-12 | 2013-07-11 | Treatment of multiple sclerosis with combination of laquinimod and fampridine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015522077A JP2015522077A (ja) | 2015-08-03 |
| JP2015522077A5 true JP2015522077A5 (enExample) | 2016-09-01 |
Family
ID=49914160
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015521792A Pending JP2015522077A (ja) | 2012-07-12 | 2013-07-11 | ラキニモドおよびファムプリジンの組合せによる多発性硬化症の治療 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20140017226A1 (enExample) |
| EP (1) | EP2872217A4 (enExample) |
| JP (1) | JP2015522077A (enExample) |
| KR (1) | KR20150038072A (enExample) |
| CN (1) | CN104582793A (enExample) |
| AR (1) | AR091724A1 (enExample) |
| AU (1) | AU2013290181A1 (enExample) |
| BR (1) | BR112015000616A2 (enExample) |
| CA (1) | CA2873229A1 (enExample) |
| EA (1) | EA201590191A1 (enExample) |
| HK (1) | HK1209672A1 (enExample) |
| IL (1) | IL236230A0 (enExample) |
| MX (1) | MX2015000485A (enExample) |
| PY (1) | PY1330684A (enExample) |
| TW (1) | TW201408300A (enExample) |
| UY (1) | UY34896A (enExample) |
| WO (1) | WO2014011827A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013116657A1 (en) | 2012-02-03 | 2013-08-08 | Teva Pharmaceutical Industries Ltd. | USE OF LAQUINIMOD FOR TREATING CROHN'S DISEASE PATIENTS WHO FAILED FIRST-LINE ANTI-TNFα THERAPY |
| JP6215238B2 (ja) | 2012-02-16 | 2017-10-18 | テバ ファーマシューティカル インダストリーズ リミティド | Ｎ−エチル−ｎ−フェニル−１，２−ジヒドロ−４，５−ジ−ヒドロキシ−１−メチル−２−オキソ−３−キノリンカルボキサミド、その製剤、および使用 |
| TW201410244A (zh) | 2012-08-13 | 2014-03-16 | Teva Pharma | 用於治療ｇａｂａ媒介之疾病之拉喹莫德（ｌａｑｕｉｎｉｍｏｄ） |
| MX2015005632A (es) | 2012-11-07 | 2016-02-05 | Teva Pharma | Sales de amina de laquinimod. |
| WO2014153145A2 (en) | 2013-03-14 | 2014-09-25 | Teva Pharmaceutical Industries Ltd. | Crystals of laquinimod sodium and improved process for the manufacture thereof |
| SG11201608674UA (en) * | 2014-04-29 | 2016-11-29 | Teva Pharma | Laquinimod for the treatment of relapsing-remitting multiple sclerosis (rrms) patients with a high disability status |
| GB2540163A (en) * | 2015-07-07 | 2017-01-11 | Univ London Queen Mary | Combination therapy for treating multiple sclerosis |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9726339D0 (en) * | 1997-12-13 | 1998-02-11 | Zeneca Ltd | Human-derived tissue-specific potassium channel |
| US20090082471A1 (en) * | 2007-09-26 | 2009-03-26 | Protia, Llc | Deuterium-enriched fingolimod |
| ES2329327B1 (es) * | 2008-03-19 | 2010-09-17 | Proyecto De Biomedicina Cima, S.L. | Combinaciones sinergicas de 5'-metiltioadenosina. |
| BRPI0903914A2 (pt) * | 2008-09-10 | 2015-07-21 | Acorda Therapeutics Inc | Uso de um composto, método para analisar a eficácia de uma composição de liberação prolongada, e, composição farmacêutica. |
| BR112012000568A2 (pt) * | 2009-06-19 | 2015-10-06 | Teva Pharma | tratamento da esclerose múltipla com laquinimod |
| JP2014530821A (ja) * | 2011-10-12 | 2014-11-20 | テバ ファーマシューティカル インダストリーズ リミティド | ラキニモドおよびフィンゴリモドを組み合わせた多発性硬化症の治療 |
-
2013
- 2013-07-09 UY UY0001034896A patent/UY34896A/es not_active Application Discontinuation
- 2013-07-10 AR ARP130102454 patent/AR091724A1/es unknown
- 2013-07-10 TW TW102124792A patent/TW201408300A/zh unknown
- 2013-07-10 PY PY201301330684A patent/PY1330684A/es unknown
- 2013-07-11 HK HK15110240.0A patent/HK1209672A1/xx unknown
- 2013-07-11 CN CN201380037036.0A patent/CN104582793A/zh active Pending
- 2013-07-11 MX MX2015000485A patent/MX2015000485A/es unknown
- 2013-07-11 WO PCT/US2013/050001 patent/WO2014011827A1/en not_active Ceased
- 2013-07-11 CA CA2873229A patent/CA2873229A1/en not_active Abandoned
- 2013-07-11 KR KR1020157003858A patent/KR20150038072A/ko not_active Withdrawn
- 2013-07-11 BR BR112015000616A patent/BR112015000616A2/pt not_active IP Right Cessation
- 2013-07-11 EP EP13816075.9A patent/EP2872217A4/en not_active Withdrawn
- 2013-07-11 JP JP2015521792A patent/JP2015522077A/ja active Pending
- 2013-07-11 AU AU2013290181A patent/AU2013290181A1/en not_active Abandoned
- 2013-07-11 EA EA201590191A patent/EA201590191A1/ru unknown
- 2013-07-11 US US13/939,306 patent/US20140017226A1/en not_active Abandoned
-
2014
- 2014-12-14 IL IL236230A patent/IL236230A0/en unknown
-
2016
- 2016-04-21 US US15/135,280 patent/US20160235735A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7650929B2 (ja) | 成人における焦点てんかんの処置のための合成経皮的カンナビジオール | |
| JP2015512406A5 (enExample) | ||
| JP2015522077A5 (enExample) | ||
| JP2010518122A5 (enExample) | ||
| FI3504187T3 (fi) | Pridopidiinin käyttö toiminnallisen heikkenemisen hoitoa varten | |
| UA107578C2 (uk) | Комбінована терапія при лікуванні діабету | |
| HK1206246A1 (en) | Use of high dose laquinimod for treating multiple sclerosis | |
| RU2010107843A (ru) | Бупропиона гидробромид и его терапевтические применения | |
| JP2013541583A5 (enExample) | ||
| JP2016510343A5 (enExample) | ||
| JP2020500864A5 (enExample) | ||
| JP2019023195A (ja) | Ｌ−４−クロロキヌレニンの剤形及び治療的使用 | |
| KR20170128633A (ko) | 탈수초성 질환 및 다른 신경계 질환을 앓는 환자에서 신경-인지 및/또는 신경-정신 손상을 개선하기 위한 4-아미노피리딘의 용도 | |
| JP2016505050A5 (enExample) | ||
| US20050282879A1 (en) | Methods and composition for treatment of migraine and symptoms thereof | |
| JP6885649B2 (ja) | 統合失調症の治療のためのイロペリドン | |
| FI3359572T3 (fi) | Menetelmä multippeliskleroosin hoitamiseksi | |
| JPH03170475A (ja) | 抑うつ症治療剤 | |
| RU2006139819A (ru) | Применение симетикона для предрасположенных к запорам пациентов | |
| US20200360303A1 (en) | Method for treating hyperhidrosis | |
| KR101978459B1 (ko) | 조루증 치료용 약학 조성물 및 조루증 치료 방법 | |
| JP2015515971A5 (enExample) | ||
| JP6420923B1 (ja) | 医薬 | |
| JP2016533323A5 (enExample) | ||
| EP2767287B1 (en) | Agent for preventing or treating htlv-i associated myelopathy |